Unibest
← Back to patent-cliff list

Maribavir

Tier C — Watch / trade

Maribavir

GSK
Originator
2021
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type

Targets:UL97

Brand:Livtencity

Indications (approved):巨细胞病毒感染

Regional status

US
Approved
2021-11-23
EU
Approved
2022-11-09
China
Approved
2023-12-19
Japan
Approved
2024-06-24

Synthetic routes & intermediates1 routes

Originator routes × 1Optimised (non-patent) × 0Process routes × 0

Routes are ordered originator first, then optimised / process (non-patent) routes; each lists steps, overall yield and the intermediate table (code / CAS / name) — ready for supplier sourcing and RFQ. Rendered by this site from structured data; no third-party route graphics used.

OriginatorRoute 1Steps 2 · Total yield 0.43 g
MARI-001142356-40-9MARI-002144490-03-9MARI-003176161-18-5API · Maribavir
CodeCAS No.Intermediate
MARI-001142356-40-9Available2-bromo-5,6-dichloro-1H-benzo[d]imidazole
MARI-002144490-03-9Available(2R,3S,4S,5S)-5-(acetoxymethyl)tetrahydrofuran-2,3,4-triyl triacetate
MARI-003176161-18-5Available(2S,3S,4S,5S)-2-(acetoxymethyl)-5-(2-bromo-5,6-dichloro-1H-benzo[d]imidazol-1-yl)tetrahydrofuran-3,4-diyl diacetate

Frequently asked questions

What are the approved indications of Maribavir?

Approved indications include: 巨细胞病毒感染.

When does the Maribavir patent expire?

No public expiry year is available for Maribavir yet; this page updates once verified.

How many synthesis routes are recorded for Maribavir?

1 synthesis routes are recorded; the shortest is 2 steps with 0.43 g total yield. Intermediates in each route carry codes and CAS numbers.

Where can I buy Maribavir intermediates?

3 intermediate CAS of Maribavir are available through the Unibest supply network — see the route tables on this page and request a quote per CAS.

How do I get a quote for Maribavir intermediates?

Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.

Source: cross-verified data (structured fields only) · 2026-09-27